Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- ChecktodayChange DetectedThe page’s interface/version indicator in the footer has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a site release rather than a change to the underlying study record content.SummaryDifference0.0%

- Check7 days agoChange DetectedRevision history updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3 in the page footer.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded a new 'Study Status' entry on 2026-03-12, and removed an older entry on 2025-10-20.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision: v3.4.3 has been added to the history and Revision: v3.4.2 has been removed.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded revision v3.4.2 to the history and removed the earlier v3.4.1.SummaryDifference0.0%

Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.